Michele Ciccarelli to Coronavirus Infections
This is a "connection" page, showing publications Michele Ciccarelli has written about Coronavirus Infections.
Connection Strength
0.042
-
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality. Eur Heart J Cardiovasc Pharmacother. 2020 11 01; 6(6):412-414.
Score: 0.007
-
Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation. Medicina (Kaunas). 2020 Oct 29; 56(11).
Score: 0.007
-
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart. 2020 10; 106(19):1512-1518.
Score: 0.007
-
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients. J Autoimmun. 2020 11; 114:102511.
Score: 0.007
-
High mortality in COVID-19 patients with mild respiratory disease. Eur J Clin Invest. 2020 Sep; 50(9):e13314.
Score: 0.007
-
Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020 10 15; 383(16):1522-1534.
Score: 0.007